VERZENIO 50 MG 14 TAB

VERZENIO 50 MG 14 TAB

3,046.00 

*recommended price

Find out how to buy and cost VERZENIO 50 MG 14 TAB in Europe you can make a request on the site.
We will help in the preparation of customs documents and accompanying documentation for delivery VERZENIO 50 MG 14 TAB , get permission from airport security.

Foreign citizens who purchase drugs while in Israel can receive a refund of VAT (TAX FREE) upon departure at the airport

Manufacturer: Eli Lilly Israel
Amount in a package: 14
Manufacturer’s website link
Description: VERZENIO 50 MG 14 TAB is an antineoplastic medication that contains the active ingredient abemaciclib. It is used to treat certain types of cancer, such as breast cancer and colorectal cancer. This medication belongs to the class of tyrosine kinase inhibitors, which block the action of certain proteins necessary for the growth and multiplication of cancer cells. VERZENIO 50 MG 14 TAB can be used as monotherapy or in combination with other antineoplastic drugs. It is intended for adult patients whose cancer has progressed after previous treatment or has metastasized. The medication should be taken under the supervision of a doctor and may cause side effects, so it is important to follow the instructions and undergo regular check-ups.
VERZENIO is a highly effective medication for treating certain types of cancer. And when it comes to purchasing this life-saving drug, buying it online is the way to go. Not only does it offer convenience and ease, but it also provides a wider selection of options and competitive prices. With just a few clicks, you can have VERZENIO delivered right to your doorstep, saving you the hassle of going to a physical store. Plus, online purchases often come with discounts and promotions, making it a more cost-effective choice. So why wait? Buy VERZENIO online and experience the benefits of convenience, affordability, and accessibility.

Reviews

There are no reviews yet.

Be the first to review “VERZENIO 50 MG 14 TAB”

Your email address will not be published.